A Clinical Study of Novel Pneumococcal Vaccine V118C in Children (V118C-002)

Clinical trial NCT07300267 · RECRUITING

Trial details

NCT number: NCT07300267
Sponsor: Merck Sharp & Dohme LLC
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Pneumococcal Infection

Start date: 2026-01-13
Primary completion: 2028-10-24
Enrollment: 210

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.